TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc.

1.33
USD
-0.06
(-4.32%)
-0.53EPS
149.02MMarket Cap
Apr 07Next Earn

Total Valuation

USD

As of June 30, 2026, TuHURA Biosciences, Inc. carries a market capitalization of 149.02M, placing it among publicly traded companies globally. Its enterprise value stands at 157.48M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap149.02M
Enterprise Value157.48M

Important Dates

TuHURA Biosciences, Inc.'s next confirmed earnings release is scheduled for April 7, 2027.

Earnings Date4/7/2027

Share Statistics

As of June 30, 2026, TuHURA Biosciences, Inc. has 63.68M shares outstanding.

Shares Outstanding63.68M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio8.18
P/TBV Ratio-39.31
P/FCF Ratio-4.49
P/OCF Ratio-4.52

Financial Position

As of June 30, 2026, TuHURA Biosciences, Inc. maintains a current ratio of 0.18, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 49.62, indicating elevated leverage, while an interest coverage ratio of -27.75 demonstrates limited ability to service its debt obligations.

Current Ratio0.18
Quick Ratio0.11
Debt / Equity49.62
Debt / EBITDA-0.30
Interest Coverage-27.75

Financial Efficiency

Over the twelve months ended June 30, 2026, TuHURA Biosciences, Inc. posted a negative return on equity (ROE) of -163.84, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -92.29, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 21.25, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)-163.84
Return on Assets (ROA)-92.29
Employee Count21.25

Stock Price Statistics

USD

As of the close on November 16, 2026, TuHURA Biosciences, Inc.'s stock has declined approximately 35.12% over the past 52 weeks. The 50-day moving average sits at 1.90, while the 200-day moving average is 2.02.

52-Week Price Change-35.12%
50-Day Moving Average1.90
200-Day Moving Average2.02

Income Statement

USD

Over the twelve months ended June 30, 2026, TuHURA Biosciences, Inc. generated - - in revenue and converted that into -30.62M in net income, yielding earnings per share of -0.53. EBITDA reached -31.10M, while operating income came in at -27.26M.

Operating Income-27.26M
Pretax Income-30.62M
Net Income-30.62M
EBITDA-31.10M
EBIT-31.20M
Earnings Per Share (EPS)-0.53

Balance Sheet

USD

As of June 30, 2026, TuHURA Biosciences, Inc. holds 995,977.00 in cash and equivalents against 9.18M in total debt, resulting in a net debt position of 7.78M. Total book value stands at 18.22M, with working capital of -7.60M providing operational flexibility.

Cash & Cash Equivalents995,977.00
Total Debt9.18M
Net Debt7.78M
Equity (Book Value)18.22M
Book Value Per Share0.29
Working Capital-7.60M

Cash Flow

USD

TuHURA Biosciences, Inc. produced -29.69M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -213,674.00 in capital expenditures, free cash flow totaled -29.90M - equivalent to -0.52 per share.

Operating Cash Flow-29.69M
Capital Expenditures-213,674.00
Free Cash Flow-29.90M
FCF Per Share-0.52

Dividends & Yields

Over the twelve months ended June 30, 2026, TuHURA Biosciences, Inc. paid dividends of 0.00 per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -22.27: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -15.02, meaning TuHURA Biosciences, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-15.02
FCF Yield-22.27

Stock Splits

TuHURA Biosciences, Inc.'s most recent stock split took place on October 18, 2024 with a 35:1 split ratio.

Last Split Date10/18/2024
Split Ratio35:1

Scores

As of June 30, 2026, TuHURA Biosciences, Inc. has an Altman Z-Score of -26.15, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-26.15